Medical Cannabis Firm Backed by Snoop Dogg Begins Trading in London nbcdfw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcdfw.com Daily Mail and Mail on Sunday newspapers.
By Alec Mattinson2021-05-20T08:02:00+01:00
Top story
Fever-Tree has continued to post “strong” off-trade sales in the early months of 2021 ahead of the re-opening of pubs, bars and restaurants and coronavirus restrictions eases around the world.
Ahead of its AGM this morning, FeverTree said its off-trade performance has remained strong in the first four months of the year and that “it is clear that at-home consumption of long mixed drinks is becoming increasingly established”.
In the UK its off-trade sales in the 13 weeks ending 18 April were up 10.1% year-on-year, despite lapping the effects of stockpiling seen at the beginning of the first lockdown in March 2020.
Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
Oxford Biomedica said production volumes would double by the end of the year to meet demand. Apart from a small batch imported from India’s Serum Institute a few months ago, all the UK supply of the Astra vaccine has been made by Oxford Biomedica and Newcastle-based Cobra Biologics.
Analysts at Liberum said: ‘This is a huge endorsement of Oxford Biomedica’s capabilities and should position the company extremely well for new partnerships outside of its traditional market.’ Shares added 10 per cent, or 104p, to reach 1106p.
Premier index the FTSE 100 was again treading water – up just 0.02 per cent, or 1.39 points, at 7034.24.